BIM 189 acts as bombesin antagonist that reduces bombesin-induced satiety.
CAT# | R0869 |
CAS | 142062-55-3 |
Synonyms/Alias | [D-Phe6,Leu13,Cpa14]bombesin-(6-14)NH2 |
M.F/Formula | C56H73ClN14O10 |
M.W/Mr. | 1137.73 |
Sequence | H-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-Phe(4-Cl)-NH2 |
Labeling Target | Vombesin |
Appearance | White lyophilised solid |
Purity | >96% |
Activity | Antagonist |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Tertiapin-Q (TPN-Q) is a small compact protein that contains twenty-one amino acids, which derived from bee veno ...
Aviptadil acetate, the nonproprietary or generic name for a vasoactive intestinal peptide (VIP), is a synthetic ...
Trifluoroacetyl tripeptide-2 (TFA-T2) is an innovative peptide compound that has garnered significant attention in dermatolog ...
Developed by the German company Hoechst Marion Roussel and derived from genetic modification of hirudin, lepirud ...
Timonacic's chemical name, L-Syrosin-4, is a new anti-tumor drug that converts cancer cells into normal cells. E ...